Pharmaceutical composition for the treatment of alzheimer's disease, method for producing same and use thereof
AssigneeFunddacao Arnaldo Vieira de Carvalho
InventorsMarielza Andrade Nunes, Hudson de Sousa Buck
Life of this patent
Estimating the term…
Abstract
The present invention provides the use of lithium compounds in micro-doses for the treatment of Alzheimer's disease. The results show that the administration of lithium in micro-doses provides a known not-toxic alternative to the elderly for slowing or stopping the progress of the disease and the progressive cognitive deterioration.
Claims5
A pharmaceutical composition for the curative or prophylactic treatment of Alzheimer's disease characterized in that it comprises
- a) a pharmaceutically acceptable carrier;
- and
- b) up to 0.28 mg daily of at least one active ingredient selected from the group comprising lithium salts or combinations thereof.
A process for the preparation of a pharmaceutical composition for the curative or prophylactic treatment of Alzheimer's disease, comprising formulating a pharmaceutically acceptable carrier with at least one active ingredient comprising between x and y (concentration) of compounds selected from lithium, or combinations thereof.
The use of lithium compounds in microdoses in the preparation of medicaments for the curative or prophylactic treatment of Alzheimer's disease.
Dependencies are inferred from the claim text.